Two mathematicians have proved that a straightforward question—how hard is it to untie a knot?—has a complicated answer.

Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...

Summary: Multidistrict litigation demands precision, speed, and coordination across a maze of data and discovery obligations. Here’s how ...

Yale researchers revealed how vitamin B5 fuels mitochondria, offering new insight into brain and metabolic disorders. The human body produces a molecule from vitamin B5 that plays a crucial role in ...

MONTREAL, Nov. 13, 2025 /CNW/ - Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep (R) (belantamab mafodotin) -- a critical new ...

Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep® (belantamab mafodotin) -- a critical new treatment option for Canadians living ...

The Pleiades (M45) is arguably the most famous star cluster in the sky. Known as the Seven Sisters, or Subaru in Japan, its ...

Invenra Inc., a U.S.-based biotechnology company pioneering multispecific antibody platform technologies, and Xcellon Biologics, a wholly owned subsidiary of Linden Lake Labs and a U.S.-based contract ...

The brain drug developer plans to slash R&D expenses by about 60% in the wake of the FDA surprisingly rejecting its rare disease drug Vyglxia.